MedTrace Logo

Magnesium, Stress and Fibromyalgia

NCT03887000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-10-23

No results posted yet for this study

Summary

Fibromyalgia affects an average of 2% of the French population. Data from the literature report that low levels of magnesium could be associated with fibromyalgia. However, no study to date has investigated the effect of oral magnesium administration on stress in fibromyalgia.

This trial therefore aims to evaluate whether magnesium could improve stress and the various disorders that contribute to the complexity of fibromyalgia, including pain, cognition, sleep disorders and quality of life.

Conditions

  • Fibromyalgia

Interventions

OTHER

magnesium

Fibromyalgia patients taking either magnesium or placebo according to the randomized plan

OTHER

placebo

Fibromyalgia patients taking either magnesium or placebo according to the randomized plan

Sponsors & Collaborators

  • CIC Inserm 1405, University Hospital Clermont-Ferrand, France

    collaborator UNKNOWN

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Gisèle PICKERING · University Hospital, Clermont-Ferrand

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-28
Primary Completion
2020-01-12
Completion
2020-05-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03887000 on ClinicalTrials.gov